Co-Authors
This is a "connection" page, showing publications co-authored by Sara Kalantari and Nikhil Narang.
Connection Strength
0.803
-
Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure. Clin Cardiol. 2021 May; 44(5):636-645.
Score: 0.183
-
Discordance Between Clinical Assessment and Invasive Hemodynamics in Patients With Advanced Heart Failure. J Card Fail. 2020 Feb; 26(2):128-135.
Score: 0.164
-
Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2020 04 07; 9(7):e014801.
Score: 0.043
-
Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices. ASAIO J. 2020 03; 66(3):253-257.
Score: 0.043
-
Effect of Concomitant Tricuspid Valve Surgery With Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2020 09; 110(3):918-924.
Score: 0.042
-
HeartWare Ventricular Assist Device Cannula Position and Hemocompatibility-Related Adverse Events. Ann Thorac Surg. 2020 09; 110(3):911-917.
Score: 0.042
-
Deep Y-Descent in Right Atrial Waveforms Following Left Ventricular Assist Device Implantation. J Card Fail. 2020 Apr; 26(4):360-367.
Score: 0.042
-
Omega-3 and hemocompatibility-related adverse events. J Card Surg. 2020 Feb; 35(2):405-412.
Score: 0.042
-
Estimation of the Severity of Aortic Insufficiency by HVAD Flow Waveform. Ann Thorac Surg. 2020 03; 109(3):945-949.
Score: 0.042
-
Hemodynamics of concomitant tricuspid valve procedures at LVAD implantation. J Card Surg. 2019 Dec; 34(12):1511-1518.
Score: 0.042
-
Aortic Insufficiency and Hemocompatibility-related Adverse Events in Patients with Left Ventricular Assist Devices. J Card Fail. 2019 Oct; 25(10):787-794.
Score: 0.041
-
Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates. Circ Heart Fail. 2019 02; 12(2):e005094.
Score: 0.039
-
Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail. 2018 10; 11(10):e005082.
Score: 0.039